Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMC 1767569)

Published in Heart on March 01, 2003

Authors

C Bartlett, P Davey, P Dieppe, L Doyal, S Ebrahim, M Egger

Articles by these authors

The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70

Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65

The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00

Do not resuscitate decisions: flogging dead horses or a dignified death? Resuscitation should not be withheld from elderly people without discussion. BMJ (2000) 14.54

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72

Misleading meta-analysis. BMJ (1995) 11.94

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol (2000) 7.95

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13

Value of flow diagrams in reports of randomized controlled trials. JAMA (2001) 7.06

Relation between agendas of the research community and the research consumer. Lancet (2000) 6.79

Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77

Who benefits from medical interventions? BMJ (1994) 5.58

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis (2006) 5.20

Why active euthanasia and physician assisted suicide should be legalised. BMJ (2001) 5.01

The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect (2001) 4.95

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading. BMJ (1999) 4.94

Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart (2006) 4.94

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med (2012) 4.82

Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health (2003) 4.67

How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess (2003) 4.62

Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ (2001) 4.47

Socioeconomic differentials in wealth and health. BMJ (1993) 4.32

Population requirement for primary hip-replacement surgery: a cross-sectional study. Lancet (1999) 4.29

The limits to demand for health care. BMJ (2000) 4.00

The moral character of clinicians or the best interests of patients? BMJ (1999) 3.96

Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ (2004) 3.86

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Magnesium and myocardial infarction. Lancet (1994) 3.74

Caring effects. Lancet (1996) 3.66

Low levels of ill health among elderly non-consulters in general practice. Br Med J (Clin Res Ed) (1984) 3.57

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation (1992) 3.56

Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2007) 3.51

Osteoarthritis: definitions and criteria. Ann Rheum Dis (1989) 3.50

HIV and male circumcision--a systematic review with assessment of the quality of studies. Lancet Infect Dis (2005) 3.49

Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2001) 3.46

Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ (1998) 3.37

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess (2001) 3.32

Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29

Smoking and health promotion in Nazi Germany. J Epidemiol Community Health (1994) 3.20

Advance directives. BMJ (1995) 3.15

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis (2012) 3.11

Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev (2004) 3.07

How policy informs the evidence. BMJ (2001) 3.06

Mannheim intima-media thickness consensus. Cerebrovasc Dis (2004) 3.05

Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A (2004) 2.88

Nurses taking on junior doctors' work: a confusion of accountability. BMJ (1996) 2.88

Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86

Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis? Int J STD AIDS (2002) 2.81

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation (1999) 2.78

Closing the gap between professional teaching and practice. BMJ (2001) 2.65

Funding clinical research. Lancet (1999) 2.63

Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis (2004) 2.57

Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients. Heart (1998) 2.54

The 'GALS' locomotor screen. Ann Rheum Dis (1992) 2.49

The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess (2005) 2.38

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed (1994) 2.38

Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis (1995) 2.36

Commentary: understanding it all--health, meta-theories, and mortality trends. BMJ (1997) 2.35

Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis (1991) 2.35

Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32

Prevalence and diagnosis of chronic respiratory symptoms in adults. BMJ (1989) 2.28

A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals. J Antimicrob Chemother (1992) 2.28

Why don't patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. J Epidemiol Community Health (2001) 2.26

Occupational activity and osteoarthritis of the knee. Ann Rheum Dis (1994) 2.26

Are randomised controlled trials in the BMJ different? BMJ (2001) 2.26

Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.24

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24

Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum (1995) 2.23

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess (2007) 2.23

Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed? Br J Gen Pract (1997) 2.22

The association between components of adult height and Type II diabetes and insulin resistance: British Women's Heart and Health Study. Diabetologia (2002) 2.22

Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis (2011) 2.15

Psychological interventions for coronary heart disease. Cochrane Database Syst Rev (2004) 2.14

Measuring handicap: the London Handicap Scale, a new outcome measure for chronic disease. Qual Health Care (1994) 2.14

Hip fractures and fluoridation in Utah's elderly population. JAMA (1992) 2.13

Arthritis in Saxon and mediaeval skeletons. Br Med J (Clin Res Ed) (1982) 2.12

Epidemiology--is it time to call it a day? Int J Epidemiol (2001) 2.12

Osteoarthritis of the knee joint: an eight year prospective study. Ann Rheum Dis (1989) 2.12

A randomized controlled trial of nursing home and long-stay geriatric ward care for elderly people. Age Ageing (1991) 2.11

Views of survivors of stroke on benefits of physiotherapy. Qual Health Care (1994) 2.09

Teaching and assessing ethics and law in the dental curriculum. Br Dent J (1999) 2.09

Cytidine deaminase may be a useful marker in differentiating elderly onset rheumatoid arthritis from polymyalgia rheumatica/giant cell arteritis. Clin Exp Rheumatol (1996) 2.08

Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06

Immobilized proteins in buffer imaged at molecular resolution by atomic force microscopy. Biophys J (1990) 2.04

Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J (Clin Res Ed) (1988) 1.99

Changing patterns of consultation in general practice: fourth national morbidity study, 1991-1992. Br J Gen Pract (1995) 1.98

Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia (2003) 1.97